U. Torresi

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

Vincenzo Catalano, Fotios Loupakis, Francesco Graziano et al. · British Journal of Cancer · 2009 · 193 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +15

Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer

Francesco Graziano, Annamaria Ruzzo, Fotios Loupakis et al. · Journal of Clinical Oncology · 2008 · 137 citations

Medicine, Oncology, Pharmacology +17

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer

Vincenzo Catalano, Fotios Loupakis, Francesco Graziano et al. · Annals of Oncology · 2011 · 116 citations · Full text

Medicine, Oncology, Surgery +16

Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer

Annamaria Ruzzo, Emanuele Canestrari, Paolo Enrico Maltese et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2007 · 62 citations

Medicine, Genetics, Oncology +11

The Role of Levamisole in the Adjuvant Treatment of Stage III Colon Cancer Patients: A Randomized Trial of 5-Fluorouracil and Levamisole Versus 5-Fluorouracil Alone

Stefano Cascinu, Vincenzo Catalano, Andrea Piga et al. · Cancer Investigation · 2003 · 20 citations

Medicine, Oncology, Pharmacotherapy +15